Nivalis Therapeutics (NVLS) Reports Q3 Loss of $0.39/Share
Tweet
Share
E-mailGet Alerts NVLS Hot Sheet
Price: $2.40 --0%
Financial Fact:
Research and development: 49.15M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 49.15M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Nivalis Therapeutics (NASDAQ: NVLS) reported Q3 EPS of ($0.39), versus ($7.68) reported last year.
For earnings history and earnings-related data on Nivalis Therapeutics (NVLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
